The efficacy of sodium-glucose cotransporter-2 inhibitors (SGLT2i) on renoprotection in lupus nephritis: a comprehensive review

Lupus nephritis (LN) is a major organ condition in systemic lupus erythematosus (SLE) leading to end-stage kidney disease if not managed effectively. Two main therapeutic approaches that are successful in the management of LN include immunosuppression and non-immunosuppressive drugs, renin-angiotens...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Shankar Prasad Nagaraju, Shilna Muttickal Swaminathan, Priya Rani, Indu Ramachandra Rao, Ravindra Prabhu Attur, Dharshan Rangaswamy, Srinivas Vinayak Shenoy, Ankur Gupta, Mohan V Bhojaraja
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Society of Diabetic Nephropathy Prevention 2025-01-01
Edice:	Journal of Nephropharmacology
Témata:	lupus nephritis sglt2i systemic lupus erythematosus proteinuria end-stage renal disease
On-line přístup:	https://jnephropharmacology.com/PDF/npj-14-e12724.pdf
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!